James A Arrighi1, Matthew Burg, Ira S Cohen, Robert Soufer. 1. Section of Cardiovascular Medicine, Deparment of Medicine, Yale University School of Medicine, New Haven, CT 06516, USA. James.Arrighi@med.va.gov
Abstract
BACKGROUND: Mental stress (MS) is an important provocateur of myocardial ischemia in many patients with chronic coronary artery disease. The majority of laboratory assessments of ischemia in response to MS have included measurements of either myocardial perfusion or function alone. We performed this study to determine the relationship between alterations in perfusion and ventricular function during MS. Methods and results Twenty-eight patients with reversible perfusion defects on exercise or pharmacologic stress myocardial perfusion imaging (MPI) underwent simultaneous technetium 99m sestamibi single photon emission computed tomography (SPECT) MPI and transthoracic echocardiography at rest and during MS according to a mental arithmetic protocol. In all cases the MS study was performed within 4 weeks of the initial exercise or pharmacologic MPI that demonstrated ischemia. SPECT studies were analyzed visually with the use of a 13-segment model and quantitatively by semiautomated circumferential profile analysis. Echocardiograms were graded on a segmental model for regional wall motion on a 4-point scale. Of 28 patients, 18 (64%) had perfusion defects and/or left ventricular dysfunction develop during MS: 9 (32%) had myocardial perfusion defects develop, 6 (21%) had regional or global left ventricular dysfunction develop, and 3 (11%) had both perfusion defects and left ventricular dysfunction develop. The overall concordance between perfusion and function criteria for ischemia during MS was only 46%. Among 9 patients with MS-induced left ventricular dysfunction, 5 had new regional wall motion abnormalities and 4 had a global decrement in function. In patients with MS-induced ischemia by SPECT, the number of reversible perfusion defects was similar during both MS and exercise/pharmacologic stress (2.8 +/- 2.0 vs 3.5 +/- 1.8, P =.41). Hemodynamic changes during MS were similar whether patients were divided on the basis of perfusion defects or left ventricular dysfunction during MS. CONCLUSIONS: These data indicate the feasibility of simultaneous assessment of perfusion and function responses during MS. Flow and function responses to MS are frequently not concordant. These data suggest that MS-induced changes in perfusion may represent a different phenomenon than MS-induced changes in left ventricular function (either globally or regionally).
BACKGROUND:Mental stress (MS) is an important provocateur of myocardial ischemia in many patients with chronic coronary artery disease. The majority of laboratory assessments of ischemia in response to MS have included measurements of either myocardial perfusion or function alone. We performed this study to determine the relationship between alterations in perfusion and ventricular function during MS. Methods and results Twenty-eight patients with reversible perfusion defects on exercise or pharmacologic stress myocardial perfusion imaging (MPI) underwent simultaneous technetium 99m sestamibi single photon emission computed tomography (SPECT) MPI and transthoracic echocardiography at rest and during MS according to a mental arithmetic protocol. In all cases the MS study was performed within 4 weeks of the initial exercise or pharmacologic MPI that demonstrated ischemia. SPECT studies were analyzed visually with the use of a 13-segment model and quantitatively by semiautomated circumferential profile analysis. Echocardiograms were graded on a segmental model for regional wall motion on a 4-point scale. Of 28 patients, 18 (64%) had perfusion defects and/or left ventricular dysfunction develop during MS: 9 (32%) had myocardial perfusion defects develop, 6 (21%) had regional or global left ventricular dysfunction develop, and 3 (11%) had both perfusion defects and left ventricular dysfunction develop. The overall concordance between perfusion and function criteria for ischemia during MS was only 46%. Among 9 patients with MS-induced left ventricular dysfunction, 5 had new regional wall motion abnormalities and 4 had a global decrement in function. In patients with MS-induced ischemia by SPECT, the number of reversible perfusion defects was similar during both MS and exercise/pharmacologic stress (2.8 +/- 2.0 vs 3.5 +/- 1.8, P =.41). Hemodynamic changes during MS were similar whether patients were divided on the basis of perfusion defects or left ventricular dysfunction during MS. CONCLUSIONS: These data indicate the feasibility of simultaneous assessment of perfusion and function responses during MS. Flow and function responses to MS are frequently not concordant. These data suggest that MS-induced changes in perfusion may represent a different phenomenon than MS-induced changes in left ventricular function (either globally or regionally).
Authors: S Shimoni; W A Zoghbi; F Xie; D Kricsfeld; S Iskander; L Gobar; I A Mikati; J Abukhalil; M S Verani; E L O'Leary; T R Porter Journal: J Am Coll Cardiol Date: 2001-03-01 Impact factor: 24.094
Authors: L Ghiadoni; A E Donald; M Cropley; M J Mullen; G Oakley; M Taylor; G O'Connor; J Betteridge; N Klein; A Steptoe; J E Deanfield Journal: Circulation Date: 2000-11-14 Impact factor: 29.690
Authors: W Jiang; M Babyak; D S Krantz; R A Waugh; R E Coleman; M M Hanson; D J Frid; S McNulty; J J Morris; C M O'Connor; J A Blumenthal Journal: JAMA Date: 1996-06-05 Impact factor: 56.272
Authors: J Douglas Bremner; Carolina Campanella; Zehra Khan; Majid Shah; Muhammad Hammadah; Kobina Wilmot; Ibhar Al Mheid; Bruno B Lima; Ernest V Garcia; Jonathon Nye; Laura Ward; Michael H Kutner; Paolo Raggi; Brad D Pearce; Amit J Shah; Arshed A Quyyumi; Viola Vaccarino Journal: Psychosom Med Date: 2018 Jul/Aug Impact factor: 4.312
Authors: Muhammad Hammadah; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Amit J Shah; Yan Sun; Brad Pearce; Ernest V Garcia; Michael Kutner; J Douglas Bremner; Fabio Esteves; Paolo Raggi; David S Sheps; Viola Vaccarino; Arshed A Quyyumi Journal: Psychosom Med Date: 2017-04 Impact factor: 4.312
Authors: Matthew M Burg; Judith Meadows; Daichi Shimbo; Karina W Davidson; Joseph E Schwartz; Robert Soufer Journal: J Am Heart Assoc Date: 2014-10-30 Impact factor: 5.501
Authors: Judith L Meadows; Samit Shah; Matthew M Burg; Steven Pfau; Robert Soufer Journal: Circ Cardiovasc Imaging Date: 2020-08-07 Impact factor: 8.589